NASDAQ Companies

Partnership focused on utilizing Axiomer™ to develop editing oligonucleotides targeting an underlying genetic variant that causes Rett syndrome Collaboration expands […]

NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company […]

RAPIDe-3, a global Phase 3 clinical study of deucrictibant for the on-demand treatment of HAE, to initiate within 1H24 Results […]

Enrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIA Confirmed with FDA that a single pivotal efficacy trial […]

10 EH/s expansion fully fundedConstruction ahead of schedule SYDNEY, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) — Iris Energy Limited (NASDAQ: […]

ADELAIDE, Australia and CAMBRIDGE, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage […]

Seoul, Jan. 05, 2024 (GLOBE NEWSWIRE) — – GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher […]

WATERTOWN, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new […]

BEIJING, Jan. 05, 2024 (GLOBE NEWSWIRE) — 17 Education & Technology Group Inc. (Nasdaq: YQ) (“17EdTech” or the “Company”), a […]

The Roundtable “AI Unleashed – Ensuring Safety and Leveraging Decentralization” Will Take Place on January 17, 2024 in Davos, Switzerland […]